Literature DB >> 20336269

[Tonsillar lymphangiomatous polyp].

M Kühnemund1, N Wernert, H Gevensleben, A O H Gerstner.   

Abstract

Lymphangiomatous polyps are rare benign lesions of the tonsils. We report the case of a female patient presenting with dysphagia of 15 years' standing due to such a lesion. After surgical excision the patient remained free of symptoms and experienced no recurrence (follow-up 17 months). The histology was characterized by epitheliotropism of lymphocytes as well as dilated lymphatic channels, blood vessels and edema. Immunohistochemical staining with D2-40 monoclonal antibody and podoplanin confirmed the diagnosis of lymphangiomatous polyps. We discuss the current literature.

Entities:  

Mesh:

Year:  2010        PMID: 20336269     DOI: 10.1007/s00106-010-2083-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  6 in total

Review 1.  Hemangiomas, lymphangiomas, and vascular malformations of the head and neck.

Authors:  S Stal; S Hamilton; M Spira
Journal:  Otolaryngol Clin North Am       Date:  1986-11       Impact factor: 3.346

Review 2.  Cystic hygroma-lymphangioma: a rare and still unclear entity.

Authors:  T L Kennedy
Journal:  Laryngoscope       Date:  1989-10       Impact factor: 3.325

3.  Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases.

Authors:  D E Kardon; B M Wenig; D K Heffner; L D Thompson
Journal:  Mod Pathol       Date:  2000-10       Impact factor: 7.842

4.  Tonsillar lymphangiomatous polyp in an adult dog.

Authors:  A D Miller; A Alcaraz; S P McDonough
Journal:  J Comp Pathol       Date:  2008-03-17       Impact factor: 1.311

5.  Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.

Authors:  J B Mulliken; J Glowacki
Journal:  Plast Reconstr Surg       Date:  1982-03       Impact factor: 4.730

6.  [Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology].

Authors:  E Kaiserling
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.